Surgical Site Infection Surveillance - Advancing the Prevention Agenda, Artykuły z zakresu dezynfekcji, Nowe ...
[ Pobierz całość w formacie PDF ]
//-->Surgical Site Infection Surveillance – Advancing the Prevention AgendaProf. Judith Tanner, De Montfort UniversityA Webber Training TeleclassSurgical Site Infec/on Surveillance – Advancing the Preven/on Agenda Professor Judith Tanner Chair of Clinical Nursing Research De Mon?ort University Hosted by Vanessa Whatley vanessa@webbertraining.com Session plan • The importance of rigorous surgical site infec/on (SSI) surveillance • Limita/ons of current SSI surveillance • An ideal SSI surveillance programme • Benefits arising from rigorous SSI surveillance www.webbertraining.com February 7, 2012 Why do we need rigorous surveillance ? • Iden/fy scale of the problem -‐ underes/mate SSI rate -‐ not important -‐ no funding for interven/ons -‐ underes/mate cost of SSIs Commonest HCAIs • Gastrointes/nal 22% • Respiratory 20% • Urinary Tract 19.7% • Surgical site 13.8% • Skin and so^ /ssue 10.5% • Primary blood 6.8% • Other 3% Third prevalence survey of HCAIs in Acute Hospitals 2006• Benchmarking not valid Why do we need rigorous surveillance ? • Iden/fy scale of the problem -‐ underes/mate SSI rate -‐ not important -‐ no funding for interven/ons -‐ underes/mate cost of SSIs Limita/ons of current system ? . • Benchmarking not valid Hosted by Vanessa Whatley vanessa@webbertraining.comwww.webbertraining.com1Surgical Site Infection Surveillance – Advancing the Prevention AgendaProf. Judith Tanner, De Montfort UniversityA Webber Training Teleclass“The Department’s approach to mandatory na/onal surveillance means there is s/ll no grip on surgical site infec/ons.” “Progress is being hit by a lack of decent data.” House of Commons Public Accounts Committee, November 2009Limita/ons of current system Limita/ons of current system • In-‐pa/ents, re-‐admissions, post discharge • Various methods used • 3 month dura/on • Voluntary versus mandatory Limita/ons of current system • In-‐pa/ents, re-‐admissions, post discharge • Various methods used • 3 month dura/on • Voluntary versus mandatory Limita/ons of current system • In-‐pa/ents, re-‐admissions, post discharge • Various methods used • 3 month dura/on • Voluntary versus mandatory Limita/ons of current system Hosted by Vanessa Whatley vanessa@webbertraining.comwww.webbertraining.com2Surgical Site Infection Surveillance – Advancing the Prevention AgendaProf. Judith Tanner, De Montfort UniversityA Webber Training TeleclassLimita/ons of current system • In-‐pa/ents, re-‐admissions, post discharge • Various methods used • 3 month dura/on • Voluntary versus mandatory The ideal SSI surveillance programme The ideal SSI surveillance programme • Full 30 day follow up – in pa/ent, readmission, post discharge • Same method • Dura/on ? • Mandatory ? • Level I and Level II data • The deep / superficial debate • Compliance data • Feedback The ideal SSI surveillance programme • Full 30 day follow up – in pa/ent, readmission, post discharge • Same method • Dura/on ? • Mandatory ? • Level I and Level II data • The deep / superficial debate • Compliance data • Feedback The ideal SSI surveillance programme • Full 30 day follow up – in pa/ent, readmission, post discharge • Same method • Dura/on ? • Mandatory ? • Level I and Level II data • The deep / superficial debate • Compliance data • Feedback The ideal SSI surveillance programme • Full 30 day follow up – in pa/ent, readmission, post discharge • Same method • Dura/on ? • Mandatory ? • Level I and Level II data • The deep / superficial debate • Compliance data • Feedback Hosted by Vanessa Whatley vanessa@webbertraining.comwww.webbertraining.com3Surgical Site Infection Surveillance – Advancing the Prevention AgendaProf. Judith Tanner, De Montfort UniversityA Webber Training TeleclassThe ideal SSI surveillance programme • Full 30 day follow up – in pa/ent, readmission, post discharge • Same method • Dura/on ? • Mandatory ? • Level I and Level II data • The deep / superficial debate • Compliance data • Feedback The ideal SSI surveillance programme • Full 30 day follow up – in pa/ent, readmission, post discharge • Same method • Dura/on ? • Mandatory ? • Level I and Level II data • The deep / superficial debate • Compliance data • Feedback The ideal SSI surveillance programme • Full 30 day follow up – in pa/ent, readmission, post discharge • Same method • Dura/on ? • Mandatory ? • Level I and Level II data • The deep / superficial debate • Compliance data • Feedback The ideal SSI surveillance programme • Full 30 day follow up – in pa/ent, readmission, post discharge • Same method • Dura/on ? • Mandatory ? • Level I and Level II data • The deep / superficial debate • Compliance data • Feedback The benefits of rigorous surveillance • Rapid surveillance feedback • Improve prac/ce • Trusts prepared to share data • ‘Real’ SSI rates • Benchmarking, commissioning, pa/ent choice • Effec/veness of interven/ons to reduce SSIs (including mul/centre studies) The benefits of rigorous surveillance • Rapid surveillance feedback • Improve prac/ce • Trusts prepared to share data • ‘Real’ SSI rates • Benchmarking, commissioning, pa/ent choice • Effec/veness of interven/ons to reduce SSIs (including mul/centre studies) Hosted by Vanessa Whatley vanessa@webbertraining.comwww.webbertraining.com4Surgical Site Infection Surveillance – Advancing the Prevention AgendaProf. Judith Tanner, De Montfort UniversityA Webber Training TeleclassThe benefits of rigorous surveillance • Rapid surveillance feedback • Improve prac/ce • Trusts prepared to share data • ‘Real’ SSI rates • Benchmarking, commissioning, pa/ent choice • Effec/veness of interven/ons to reduce SSIs (including mul/centre studies) The benefits of rigorous surveillance • Rapid surveillance feedback • Improve prac/ce • Trusts prepared to share data • ‘Real’ SSI rates • Benchmarking, commissioning, pa/ent choice • Effec/veness of interven/ons to reduce SSIs (including mul/centre studies) The benefits of rigorous surveillance • Rapid surveillance feedback • Improve prac/ce • Trusts prepared to share data • ‘Real’ SSI rates • Benchmarking, commissioning, pa/ent choice • Effec/veness of interven/ons to reduce SSIs (including mul/centre studies) The benefits of rigorous surveillance • Rapid surveillance feedback • Improve prac/ce • Trusts prepared to share data • ‘Real’ SSI rates • Benchmarking, commissioning, pa/ent choice • Effec/veness of interven/ons to reduce SSIs (including mul/centre studies) 8 February(FREE … WHO Teleclass)BehaviouralChange in InfectionPrevention and ControlSpeaker: Prof. Andreas Voss, Nimjen University, Netherlands15 Februaryof Vaccine-PreventableDiseases – Communicating the Science and Closingthe GapsSpeaker: Dr. Nikki Turner, University of Auckland, New Zealand(South Pacific Teleclass)Outbreak23 FebruaryThe Biofilm Hypothesis of Chronic InfectionSpeaker: Dr. Phillip Stewart, Center for Biofilm Engineering,University of Montana1 MarchDeveloping a Sustainable and Effective Approach toHygiene and Infection Prevention in Home and EverydaySettingsHosted by Vanessa Whatley vanessa@webbertraining.comwww.webbertraining.com5
[ Pobierz całość w formacie PDF ]